What is the share price of Godavari Drugs Ltd (GODAVARI) today?
The share price of GODAVARI as on 16th July 2025 is ₹89.45. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Godavari Drugs Ltd (GODAVARI) share?
The past returns of Godavari Drugs Ltd (GODAVARI) share are- Past 1 week: -1.11%
- Past 1 month: -5.80%
- Past 3 months: -7.68%
- Past 6 months: -15.97%
- Past 1 year: -16.17%
- Past 3 years: 48.10%
- Past 5 years: 200.67%
What are the peers or stocks similar to Godavari Drugs Ltd (GODAVARI)?
The peers or stocks similar to Godavari Drugs Ltd (GODAVARI) include:What is the market cap of Godavari Drugs Ltd (GODAVARI) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Godavari Drugs Ltd (GODAVARI) is ₹67.02 Cr as of 16th July 2025.What is the 52 week high and low of Godavari Drugs Ltd (GODAVARI) share?
The 52-week high of Godavari Drugs Ltd (GODAVARI) is ₹155 and the 52-week low is ₹79.What is the PE and PB ratio of Godavari Drugs Ltd (GODAVARI) stock?
The P/E (price-to-earnings) ratio of Godavari Drugs Ltd (GODAVARI) is 15.30. The P/B (price-to-book) ratio is 1.72.Which sector does Godavari Drugs Ltd (GODAVARI) belong to?
Godavari Drugs Ltd (GODAVARI) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Godavari Drugs Ltd (GODAVARI) shares?
You can directly buy Godavari Drugs Ltd (GODAVARI) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Godavari Drugs Ltd
GODAVARI Share Price
89.450.51% (+0.45)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
GODAVARI Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
AvgCan be considered moderately valued vs the market
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
GODAVARI Performance & Key Metrics
GODAVARI Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 15.27 | 1.72 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 37.80 | 6.51 | 0.80% |
GODAVARI Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
GODAVARI Company Profile
Godavari Drugs is engaged in the contract manufacturing, loan license manufacturing, manufacturing and supply of active pharmaceutical ingredients (APIs), drug intermediaries and fine chemicals
SUNPHARMA
PE Ratio
37.93
37.93
1Y Return
8.91%
8.91%
Buy Reco %
84.85
84.85
CIPLA
PE Ratio
22.84
22.84
1Y Return
1.73%
1.73%
Buy Reco %
68.75
68.75
TORNTPHARM
PE Ratio
60.91
60.91
1Y Return
16.45%
16.45%
Buy Reco %
70.83
70.83
MANKIND
PE Ratio
54.95
54.95
1Y Return
23.38%
23.38%
Buy Reco %
81.25
81.25
DRREDDY
PE Ratio
18.55
18.55
1Y Return
7.22%
7.22%
Buy Reco %
48.39
48.39
GODAVARI Forecast
GODAVARI Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
GODAVARI
GODAVARI
Income
Balance Sheet
Cash Flow
Annual Normal View
GODAVARI Income Statement
GODAVARI Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 76.40 | 65.13 | 83.78 | 96.03 | 123.08 | 161.39 | 160.50 | 157.33 | 114.33 | 114.33 | ||||||||||
Raw Materials | 63.25 | 48.18 | 66.95 | 77.38 | 94.15 | 127.97 | 137.82 | 121.95 | 101.52 | 101.52 | ||||||||||
| Power & Fuel Cost | 4.57 | 3.98 | 4.20 | 4.84 | 4.76 | 5.46 | 6.66 | 8.51 | ||||||||||||
| Employee Cost | 2.38 | 2.67 | 3.45 | 3.45 | 3.94 | 4.96 | 4.84 | 5.13 | ||||||||||||
| Selling & Administrative Expenses | 0.96 | 0.98 | 0.91 | 1.29 | 1.24 | 1.38 | 1.27 | 1.50 | ||||||||||||
| Operating & Other expenses | -0.78 | 4.60 | 2.56 | 2.70 | 8.74 | 10.04 | -0.88 | 6.41 | ||||||||||||
EBITDA | 6.02 | 4.72 | 5.71 | 6.37 | 10.25 | 11.58 | 10.79 | 13.83 | 12.81 | 12.81 | ||||||||||
| Depreciation/Amortization | 0.81 | 0.99 | 1.09 | 1.16 | 1.22 | 1.70 | 1.94 | 1.99 | 2.45 | 2.44 | ||||||||||
| PBIT | 5.21 | 3.73 | 4.62 | 5.21 | 9.03 | 9.88 | 8.85 | 11.84 | 10.36 | 10.37 | ||||||||||
| Interest & Other Items | 2.51 | 2.42 | 2.89 | 2.91 | 3.32 | 2.85 | 3.93 | 4.92 | 4.73 | 4.74 | ||||||||||
| PBT | 2.70 | 1.31 | 1.73 | 2.30 | 5.71 | 7.03 | 4.92 | 6.92 | 5.63 | 5.63 | ||||||||||
| Taxes & Other Items | 0.89 | 0.49 | 0.54 | 0.29 | 1.58 | 1.78 | 1.15 | 1.38 | 1.25 | 1.24 | ||||||||||
| Net Income | 1.81 | 0.82 | 1.19 | 2.01 | 4.13 | 5.25 | 3.77 | 5.54 | 4.38 | 4.39 | ||||||||||
| EPS | 2.40 | 1.09 | 1.58 | 2.67 | 5.48 | 6.97 | 5.01 | 7.36 | 5.82 | 5.83 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
GODAVARI Company Updates
GODAVARI Stock Peers
GODAVARI Past Performance & Peer Comparison
GODAVARI Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation-basic on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Godavari Drugs Ltd | 15.30 | 1.72 | — |
| Sun Pharmaceutical Industries Ltd | 37.93 | 5.72 | 0.93% |
| Cipla Ltd | 22.84 | 3.85 | 1.07% |
| Torrent Pharmaceuticals Ltd | 60.91 | 15.34 | 0.93% |
GODAVARI Stock Price Comparison
Compare GODAVARI with any stock or ETFCompare GODAVARI with any stock or ETF
GODAVARI
GODAVARI Holdings
GODAVARI Shareholdings
GODAVARI Promoter Holdings Trend
GODAVARI Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
GODAVARI Institutional Holdings Trend
GODAVARI Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
GODAVARI Shareholding Pattern
GODAVARI Shareholding Pattern
GODAVARI Shareholding History
GODAVARI Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing GODAVARI stock
smallcases containing GODAVARI stock
Looks like this stock is not in any smallcase yet.
GODAVARI Events
GODAVARI Events
GODAVARI Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
GODAVARI has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
GODAVARI Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
GODAVARI has not given any dividends in last 5 years
GODAVARI Dividends
GODAVARI Dividends
Hmm, looks like data is unavailable here. Please come back after some timeGODAVARI Stock News & Opinions
GODAVARI Stock News & Opinions
Articles & Videos
Earnings
Godavari Drugs standalone net profit declines 66.54% in the March 2025 quarter
Net profit of Godavari Drugs declined 66.54% to Rs 0.89 crore in the quarter ended March 2025 as against Rs 2.66 crore during the previous quarter ended March 2024. Sales declined 34.01% to Rs 25.50 crore in the quarter ended March 2025 as against Rs 38.64 crore during the previous quarter ended March 2024. For the full year,net profit declined 21.08% to Rs 4.38 crore in the year ended March 2025 as against Rs 5.55 crore during the previous year ended March 2024. Sales declined 27.67% to Rs 113.35 crore in the year ended March 2025 as against Rs 156.71 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales25.5038.64 -34 113.35156.71 -28 OPM %12.2011.57 -10.448.49 - PBDT2.113.35 -37 8.089.00 -10 PBT1.442.82 -49 5.637.01 -20 NP0.892.66 -67 4.385.55 -21 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Godavari Drugs to discuss results
Godavari Drugs will hold a meeting of the Board of Directors of the Company on 29 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Godavari Drugs standalone net profit declines 36.89% in the December 2024 quarter
Net profit of Godavari Drugs declined 36.89% to Rs 0.77 crore in the quarter ended December 2024 as against Rs 1.22 crore during the previous quarter ended December 2023. Sales declined 31.45% to Rs 29.55 crore in the quarter ended December 2024 as against Rs 43.11 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales29.5543.11 -31 OPM %8.708.17 - PBDT1.562.30 -32 PBT0.921.80 -49 NP0.771.22 -37 Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Godavari Drugs to declare Quarterly Results
Godavari Drugs will hold a meeting of the Board of Directors of the Company on 12 February 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Godavari Drugs standalone net profit rises 26.74% in the September 2024 quarter
Net profit of Godavari Drugs rose 26.74% to Rs 1.09 crore in the quarter ended September 2024 as against Rs 0.86 crore during the previous quarter ended September 2023. Sales declined 34.02% to Rs 26.09 crore in the quarter ended September 2024 as against Rs 39.54 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales26.0939.54 -34 OPM %11.127.76 - PBDT1.831.77 3 PBT1.251.28 -2 NP1.090.86 27 Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Godavari Drugs to convene board meeting
Godavari Drugs will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
8 months agoCapital Market - Live
Earnings
Godavari Drugs standalone net profit rises 101.23% in the June 2024 quarter
Net profit of Godavari Drugs rose 101.23% to Rs 1.63 crore in the quarter ended June 2024 as against Rs 0.81 crore during the previous quarter ended June 2023. Sales declined 9.06% to Rs 32.21 crore in the quarter ended June 2024 as against Rs 35.42 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales32.2135.42 -9 OPM %10.036.35 - PBDT2.561.59 61 PBT2.011.12 79 NP1.630.81 101 Powered by Capital Market - Live
11 months agoCapital Market - Live
Corporate
Godavari Drugs to discuss results
Godavari Drugs will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live
11 months agoCapital Market - Live
Godavari Drugs Standalone March 2022 Net Sales at Rs 44.28 crore, up 34.35% Y-o-Y
3 years agoMoneycontrol
Godavari Drugs standalone net profit declines 1.55% in the March 2022 quarter
3 years agoBusiness Standard
Over the last 5 years, revenue has grown at a yearly rate of 3.55%, vs industry avg of 10.15%
Over the last 5 years, market share decreased from 0.04% to 0.03%
Over the last 5 years, net income has grown at a yearly rate of 16.86%, vs industry avg of 20.04%